Lee Shun Chong

This inventor holds 30 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 6 EPO patents, primarily in Antiviral Compounds. Top assignees: Gilead Sciences, Inc., Schering-Plough Animal Health Corporation. Active years: 2006-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lee Shun Chong. Retrieved from https://idiyas.com/inventor/lee-shun-chong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 5)

% Patents Active = 76.7

CIPO Patents = 4

EPO Patents = 6 (Patent Applications = 4)

Average Co-Inventor Count = 7.7

ph-index = 15

Forward Citations = 579(Granted Patents)

Company Filing History:

29 out of 946

Gilead Sciences, Inc.

patents

1 out of 30

Schering-Plough Animal Health Corporation

patents

Years Active: 2006-2024

Loading Chart...

Areas of Expertise:

Quinazoline Derivatives

Phosphonate Analogs

Viral Infections

Flaviviridae Inhibitors

Pyrido Compounds

Hematological Malignancies

Toll-Like Receptor Modulators

Cancer Treatment

Immuno-Modulatory Activity

Metabolic Diseases

Antibiotics

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12049461 - 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections (2024-07-30),

2. 10882851 - 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections (2021-01-05),

3. 10144736 - Substituted pteridines useful for the treatment and prevention of viral infections (2018-12-04),

4. 9259426 - 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections (2016-02-16),

5. 9139604 - Antiviral phosphonate analogs (2015-09-22),

6. 8884030 - [object Object] (2014-11-11),

7. 8871785 - Antiviral phosphonate analogs (2014-10-28),

8. 8765722 - Inhibitors of flaviviridae viruses (2014-07-01),

9. 8729089 - Pyrido(3,2-d)pyrimidines useful for treating viral infections (2014-05-20),

10. 8673929 - 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections (2014-03-18),

11. 8637531 - Pyrido(3,2-d)pyridmidines useful for treating viral infections (2014-01-28),

12. 8569302 - Inhibitors of flaviviridae viruses (2013-10-29),

13. 8536187 - 2,4,6-trisubstituted pyrido(3,2-d)pyrimidines useful for treating viral infections (2013-09-17),

14. 8524764 - [object Object] (2013-09-03),

15. 8501714 - [object Object] (2013-08-06),

Title: The Innovative Journey of Lee Shun Chong

Introduction: Lee Shun Chong, a pioneering inventor based in Newark, CA, has made significant contributions to the world of technology and innovation. As a talented female inventor, she has been at the forefront of groundbreaking developments in various fields.

Latest Patents: Lee Shun Chong holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced robotics. Her most recent patents focus on enhancing the efficiency of solar power systems and improving the functionality of autonomous drones.

Career Highlights: Throughout her illustrious career, Lee Shun Chong has been recognized for her innovative spirit and dedication to creating solutions that address pressing global challenges. She has received numerous awards for her groundbreaking inventions and has been invited to speak at prestigious conferences around the world.

Collaborations: Lee Shun Chong has collaborated with leading research institutions, universities, and tech companies to further her research and bring her inventions to life. Her collaborative efforts have resulted in cutting-edge technologies that have the potential to revolutionize industries.

Conclusion: Lee Shun Chong's passion for innovation, coupled with her relentless drive to push the boundaries of what is possible, has solidified her reputation as a trailblazing inventor. Her work continues to inspire the next generation of inventors and serves as a testament to the power of creativity and perseverance in driving positive change.

Profile summary based on public USPTO records.